Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for combining different screening strategies.

Robert H Fletcher1

  • 1Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA.

Gastrointestinal Endoscopy Clinics of North America
|March 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death.

JAMA network open·2024
Same author

The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer.

Journal of medical screening·2020
Same author

Aspirin before fecal immunochemical testing did not increase sensitivity for detecting advanced colorectal neoplasms.

Annals of internal medicine·2019
Same author

Guideline: Experts recommend against prostate cancer screening with prostate-specific antigen test.

Annals of internal medicine·2019
Same author

Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.

Gastroenterology·2018
Same author

Colonoscopy outreach increased CRC screening more than FIT outreach; both were better than usual care.

Annals of internal medicine·2017
Same journal

Transform-The Path Forward: Endoscopy and the Science of Expertise.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

Ushering in a New Era of Training in Endoscopy.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

Where Do We Go from Here: Transforming Teaching Endoscopy Knowledge Using the Expert Performance Approach.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

Integrating Artificial Intelligence into Endoscopy Training.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

From Expert to Educator: Translating Expert Performance into Teachable Competencies Through Trainer Development in Endoscopic Simulation.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

Implementing Endoscopy Simulation Nationally.

Gastrointestinal endoscopy clinics of North America·2026
See all related articles

Screening for colorectal cancer using both fecal occult blood testing (FOBT) and sigmoidoscopy may not be sufficiently proven to be superior to individual tests. Prioritizing widespread screening participation is crucial.

Area of Science:

  • Gastroenterology
  • Preventive Medicine
  • Public Health

Background:

  • Screening programs require benefits to substantially outweigh harms.
  • Ethical considerations differ between routine medical practice and initiated screening procedures.
  • Screening requires conclusive evidence of altering disease natural history.

Purpose of the Study:

  • To evaluate the evidence supporting combined fecal occult blood testing (FOBT) and sigmoidoscopy for colorectal cancer screening.
  • To determine if combined screening offers significant advantages over individual tests.
  • To address the dilemma of recommending combined screening with limited evidence.

Main Methods:

  • Review of existing evidence on the effectiveness and safety of colorectal cancer screening modalities.

Related Experiment Videos

  • Analysis of expert group recommendations for combined FOBT and sigmoidoscopy.
  • Comparison of evidence strength for combined versus individual screening tests.

    • Main Results:

    • Evidence for the additional effectiveness of combined FOBT and sigmoidoscopy is less robust than for individual tests.
    • The magnitude of benefit from combined screening is not clearly established.
    • There is ongoing debate regarding the sufficiency of evidence for combined screening.

    Conclusions:

    • Recommending combined FOBT and sigmoidoscopy over individual tests for colorectal cancer screening is premature.
    • The primary national priority should be increasing overall participation in colorectal cancer screening.
    • Further research is needed to definitively establish the benefits of combined screening strategies.